Anaplastic Large Cell Lymphoma
FDA safety alert: Cancers reported in scar tissue around breast implants
FDA issued a safety alert Thursday regarding reports of squamous cell carcinoma and various lymphomas in the scar tissue surrounding breast implants.
Top in hem/onc: Hormone therapy and breast cancer recurrence; rise in rare malignancy
A recent study showed that menopausal hormone therapy or vaginal estrogen therapy did not increase the risk for breast cancer recurrence among postmenopausal women with early-stage, ER-positive disease.
Incidence of lymphoma subtype linked to breast implants rises rapidly in US
Age-adjusted incidence of anaplastic large-cell lymphoma of the breast rapidly increased in the U.S. between 2000 and 2018, according to a research letter published in JAMA Oncology.
FDA approves Xalkori for lymphoma subset
The FDA approved crizotinib for treatment of certain patients with systemic anaplastic large cell lymphoma.
FDA grants priority review to Xalkori for certain children with lymphoma
The FDA granted priority review to crizotinib for the treatment of certain children with lymphoma, according to the agent’s manufacturer.